(Q57451095)

6

0 references

Gian Vincenzo Zuccotti

object named as

Gian Vincenzo Zuccotti

1

0 references

author name string

Andrea Scaramuzza

2

0 references

Sara Riboni

3

0 references

Chiara Mameli

4

0 references

Alessandro Zanetti

7

0 references

Giovanni Radaelli

Incidence of influenza and associated illness in children aged 0-19 years: a systematic review

8

0 references

language of work or name

English

0 references

publication date

August 2009

0 references

published in

Vaccine

0 references

volume

27

0 references

issue

39

0 references

page(s)

5357-5362

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Antibody induction by influenza vaccines in the elderly: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Impact of respiratory virus infections on persons with chronic underlying conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Impact of epidemic type A influenza in a defined adult population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Influenza- and RSV-associated hospitalizations among adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Incidence of outpatient visits and hospitalizations related to influenza in infants and young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Influenza vaccination: policy versus evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Inflexal V a trivalent virosome subunit influenza vaccine: production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Virosomal adjuvanted antigen delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Clinical experience with inactivated, virosomal influenza vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Virosome influenza vaccine in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

The immune response to influenza vaccination in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Influenza immunization in adults with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Uptake of influenza vaccination among children with diabetes--a re-audit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

7 January 2021

A history of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082

The virosome concept for influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.082